CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive: More importantly, when analyzing different cancer cell lines (Supplemental Data 5), we found CXCL12 was lowly expressed among most hematopoietic neoplasms, especially in AML and chronic myelocytic leukemia (CML).